Persistent Lower Urinary Tract Symptoms After BPH Surgery

Launer BM, McVary KT, Ricke WA, Lloyd GL. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2021;127(6):722–8. https://doi.org/10.1111/bju.15286.

Article  PubMed  Google Scholar 

Ibis MA, Cayan S, Tokatli Z, Orhan I, Asci R, Kocamanoglu F, et al. Trends in benign prostatic hyperplasia surgery over the years: a multicenter 14-year retrospective study. Turk J Urol. 2021;47(6):501–8. https://doi.org/10.5152/tud.2021.21262.

Article  PubMed  PubMed Central  Google Scholar 

Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–96. https://doi.org/10.1016/j.eururo.2014.06.017.

Article  PubMed  Google Scholar 

•• Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE part II-surgical evaluation and treatment. J Urol. 2021;206(4):818–26. https://doi.org/10.1097/JU.0000000000002184. This is the current AUA guidelines for management of BPH symptoms and should be understood by all clinicans treating BPH.

Article  PubMed  Google Scholar 

•• Gravas S, Gacci M, Gratzke C, Herrmann TRW, Karavitakis M, Kyriazis I, et al. Summary paper on the 2023 European association of urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol. 2023;84(2):207–22. https://doi.org/10.1016/j.eururo.2023.04.008. This is the most recent EUA guidelines for the management of LUTS which is essential for all urologists to review.

Article  PubMed  Google Scholar 

• Te AE, Cho A, Chughtai BI. How i handle retreatment of LUTS following a failed MIST. Curr Urol Rep. 2021;22(8):40. https://doi.org/10.1007/s11934-021-01054-w. Recent review of the management of LUTS after failed minimally invasive treatments of various technologies for BPH.

Article  PubMed  Google Scholar 

Kim A, Hak AJ, Choi WS, Paick SH, Kim HG, Park H. Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: nations-wide health insurance study. Urology. 2021;154:300–7. https://doi.org/10.1016/j.urology.2021.04.019.

Article  PubMed  Google Scholar 

Campbell J, Reid J, Ordon M, Welk B. The utilization of benign prostatic hyperplasia and bladder-related medications after a transurethral prostatectomy. Urology. 2019;130:126–31. https://doi.org/10.1016/j.urology.2019.05.003.

Article  PubMed  Google Scholar 

Chughtai B, Simma-Chiang V, Kaplan SA. Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms. Curr Urol Rep. 2014;15(9):434. https://doi.org/10.1007/s11934-014-0434-1.

Article  PubMed  Google Scholar 

Rieken M, de Nunzio C, Cornu JN, Ramasamy R, Misrai V, Malde S, et al. Medical treatment incidence and persistence after surgical relief of lower urinary tract symptoms suggestive of benign prostatic obstruction: a critical analysis of the literature. Eur Urol Focus. 2023. https://doi.org/10.1016/j.euf.2023.08.013.

Article  PubMed  Google Scholar 

Mirone V, Imbimbo C, Longo N, Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol. 2007;51(1):57–66. https://doi.org/10.1016/j.eururo.2006.07.050.

Article  PubMed  Google Scholar 

Bosch R, Abrams P, Averbeck MA, Finazzi Agro E, Gammie A, Marcelissen T, et al. Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018. Neurourol Urodyn. 2019;38(Suppl 5):S56–65. https://doi.org/10.1002/nau.24076.

Article  PubMed  PubMed Central  Google Scholar 

Han HH, Ko WJ, Yoo TK, Oh TH, Kim DY, Kwon DD, et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology. 2014;84(3):675–80. https://doi.org/10.1016/j.urology.2014.04.027.

Article  PubMed  Google Scholar 

Tsai CH, Fan YH, Lin ATL, Huang WJ. Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia. Low Urin Tract Symptoms. 2022;14(5):329–33. https://doi.org/10.1111/luts.12438.

Article  CAS  PubMed  Google Scholar 

Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol. 2006;50(5):969–79. https://doi.org/10.1016/j.eururo.2005.12.042. discussion 80.

Article  PubMed  Google Scholar 

Singla N, Singla AK. Evaluation and management of lower urinary tract symptoms after outlet surgery for benign prostatic hyperplasia. Curr Bladder Dysfunct Rep. 2016;11(3):242–7. https://doi.org/10.1007/s11884-016-0376-1.

Article  PubMed  PubMed Central  Google Scholar 

Habib E, Abdallah MF, ElSheemy MS, Badawy MH, Nour HH, Kamal AM, et al. Holmium laser enucleation versus bipolar resection in the management of large-volume benign prostatic hyperplasia: a randomized controlled trial. Int J Urol. 2022;29(2):128–35. https://doi.org/10.1111/iju.14737.

Article  CAS  PubMed  Google Scholar 

Fenton AS, Morey AF, Aviles R, Garcia CR. Anterior urethral strictures: etiology and characteristics. Urology. 2005;65(6):1055–8. https://doi.org/10.1016/j.urology.2004.12.018.

Article  PubMed  Google Scholar 

Sekar H, Palaniyandi V, Krishnamoorthy S, Kumaresan N. Post-transurethral resection of prostate urethral strictures: are they often underreported? A single-center retrospective observational cohort study. Urol Ann. 2021;13(4):329–35. https://doi.org/10.4103/UA.UA_165_19.

Article  PubMed  PubMed Central  Google Scholar 

Kuo HC. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy. Urol Int. 2002;68(2):99–104. https://doi.org/10.1159/000048427.

Article  PubMed  Google Scholar 

Wessells H, Morey A, Souter L, Rahimi L, Vanni A. Urethral stricture disease guideline amendment (2023). J Urol. 2023;210(1):64–71. https://doi.org/10.1097/JU.0000000000003482.

Article  PubMed  Google Scholar 

Elliott SP, Coutinho K, Robertson KJ, D’Anna R, Chevli K, Carrier S, et al. One-year results for the ROBUST III randomized controlled trial evaluating the optilume® drug-coated balloon for anterior urethral strictures. J Urol. 2022;207(4):866–75. https://doi.org/10.1097/JU.0000000000002346.

Article  PubMed  Google Scholar 

Castellani D, Wroclawski ML, Pirola GM, Gauhar V, Rubilotta E, Chan VW, et al. Bladder neck stenosis after transurethral prostate surgery: a systematic review and meta-analysis. World J Urol. 2021;39(11):4073–83. https://doi.org/10.1007/s00345-021-03718-1.

Article  PubMed  Google Scholar 

Zhang L, Liu S, Wu K, Mu X, Yang L. Management of highly recurrent bladder neck contractures via transurethral resection combined with intra- and post-operative triamcinolone acetonide injections. World J Urol. 2021;39(2):527–32. https://doi.org/10.1007/s00345-020-03224-w.

Article  CAS  PubMed  Google Scholar 

Kallidonis P, Spinos T, Peteinaris A, Somani B, Liatsikos E. Salvage holmium laser enucleation of the prostate after previous interventions: a systematic review. BJU Int. 2024;133(2):141–51. https://doi.org/10.1111/bju.16131.

Article  CAS  PubMed  Google Scholar 

Lomas DJ, Krambeck AE. Long-term efficacy of holmium laser enucleation of the prostate in patients with detrusor underactivity or acontractility. Urology. 2016;97:208–11. https://doi.org/10.1016/j.urology.2016.07.010.

Article  PubMed  Google Scholar 

Large T, Krambeck AE. Evidence-based outcomes of holmium laser enucleation of the prostate. Curr Opin Urol. 2018;28(3):301–8. https://doi.org/10.1097/MOU.0000000000000498.

Article  PubMed  Google Scholar 

Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, et al. Incontinence after prostate treatment: AUA/SUFU guideline. J Urol. 2019;202(2):369–78. https://doi.org/10.1097/JU.0000000000000314.

Article  PubMed  Google Scholar 

Elshal AM, Elmansy HM, Elhilali MM. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). BJU Int. 2012;110(11Pt C):E845–50. https://doi.org/10.1111/j.1464-410X.2012.11290.x.

Article  PubMed  Google Scholar 

Abdelaziz A, Bhandari M, Elshabrawy A, Trecarten S, Dalla EE, Samara KA, et al. Contemporary trends of holmium laser enucleation of the prostate (HoLEP) utilization in the United States: a comprehensive analysis using the National Surgical Quality Improvement Program (NSQIP) database (2011–2020). J Endourol. 2024. https://doi.org/10.1089/end.2023.0612.

Article  PubMed  Google Scholar 

Gauhar V, Lim EJ, Khan TY, Law YXT, Choo ZW, Castellani D, et al. Rezum to the rescue: early outcomes of Rezum on patients with recurrent lower urinary tract symptoms after surgical interventions for benign prostatic enlargement. Andrologia. 2022;54(8):e14450. https://doi.org/10.1111/and.14450.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif